Document is current
Any future updates will be listed below
-
Authors
Amin, Faisal Mohammad
Linnet, Thor
Cullum, Christopher Kjaer
Do, Thien Phu
Younis, Samaira
- License Information
-
More Information
Article History
Received: 18 February 2025
Accepted: 5 June 2025
First Online: 1 July 2025
Declarations
:
: See ‘’ section.
: TPD reports personal fees from Teva, outside of the submitted work. FMA has received Honoria or personal fees from Pfizer, Teva, Novartis, Lundbeck, AbbVie and Eli Lilly for lecturing or participating in advisory boards; is principal investigator for phase IV trials sponsored by Novartis and by Teva; serves as president of Danish Headache Society and board member of the European Headache Federation; serves as associate editor for Acta Neurol Scand, Front Neurol, Front Res Pain, and Headache Medicine.
